This announcement is a separate document:
泰格医药：关于终止2022年A股限制性股票激励计划并作废限制性股票事项之法律意见书
Tiger Pharmaceuticals: Legal Opinion on the Termination of the 2022 A-Share Restricted Stock Incentive Plan and the Cancellation of Restricted Shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.